medigraphic.com

2014, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (5)

Prognostic factors in elderly patient meningioma

Villalpando-Navarrete E, Rosas-Peralta VH, Sandoval-Balanzario MA

Language: Spanish
References: 35
Page: 530-537
PDF size: 196.46 Kb.


ABSTRACT

Background: Frequently, therapeutic decisions must be made in order to manage meningioma in geriatric patients. This study analyzes the prognostic factors, as well as the Clinical Radiological Grading Score (CRGS) as a complement to make therapeutic decisions.
Methods: A retrospective study was conducted between 2009 and 2010. The study population consisted of 28 patients over 65 years of age. We analyzed clinical, imaging and histopathological factors. We used the χ2 test and the Fisher exact test for quantitative variables, as well as the Mann-Whitney U for qualitative variables.
Results: Overall mortality at 3, 6 and 12 months of follow-up was 7.14, 10.71 and 14.28 %, respectively. The analysis revealed that performance status with Karnofsky scale (p = 0.02), the location of the lesion (p = 0.002), histopathological malignancy grade (p = 0.038), and a score lower than 10 on the CRGS (p = 0.003) were associated with poor prognosis.
Conclusion: The neurosurgical management of geriatric patients is a therapeutic option with a favorable prognosis in patients with a score equal to or greater than 10 and those with adequate functional status.


REFERENCES

  1. CBTRUS. CBTRUS Statistical Report: Primary brain and central nervous system tumors diagnosed in the United States in 2004-2007. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2011. Texto libre en http://www.cbtrus.org/2011-NPCRSEER/ WEB-0407-Report-3-3-2011.pdf

  2. Radhakrishnan K, Mokri B, Parisi JE, O’Fallon WM, Sunku J, Kurland LT. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol. 1995;37(1):67-73.

  3. Braunstein JB, Vick NA. Meningiomas: the decision not to operate. Neurology. 1997;48(5):1459-62.

  4. Comu P, Chatellier G, Dagreou F, Clemenceau S, Foncin JF, Rivierez M, et al. Intracraneal meningiomas in elderly patients. Postoperative morbidity and mortality. Factors predictive of outcome. Acta Neurochir. 1990;102(3-4):98-102.

  5. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA. 1961;178:261-6.

  6. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22-39.

  7. Louis DN, Cavenee WK, Ohgaki H, Wiestler OD, editors. WHO classifi cation of tumours of the central nervous system. 4th ed. Lyon: International Agency for Research on Cancer; 2007.

  8. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975 Mar 1;1(7905):480-4.

  9. Djindjian M, Caron JP, Athayde AA, Février MJ. Intracranial meningiomas in the elderly (over 70 years old). A retrospective study of 30 surgical cases. Acta Neurochir. 1988;90(3-4):121-3.

  10. Mastronardi L, Ferrante L, Qasho R, Ferrari V, Tatarelli R, Fortuna A. Intracranial meningiomas in the 9th decade of life: a retrospective study of 17 surgical cases. Neurosurgery. 1995;36(2):270-4.

  11. Sacko O, Sesay M, Roux FE, Riem T, Grenier B, Liguoro D, et al. Intracranial meningioma surgery in the ninth decade of life. Neurosurgery. 2007;61(5):950-4.

  12. D’Andrea G, Roperto R, Caroli E, Crispo F, Ferrante L. Thirty-seven cases of intracranial meningiomas in the ninth decade of life: our experience and review of the literature. Neurosurgery. 2005;56(5):956-61.

  13. Boviatsis EJ, Bouras TI, Kouyialis AT, Themistocleous MS, Sakas DE. Impact of age on complications and outcome in meningioma surgery. Surg Neurol. 2007;68(4):407-11.

  14. Schneider AJ. Assessment of risk factors and surgical outcome. Surg Clin North Am. 1983;63(5):1113-26.

  15. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer. 1948;1(4):634-56.

  16. Asano K, Nakano T, Takeda T, Ohkuma H. Risk factors for postoperative systemic complications in elderly patients with brain tumors. Clinical article. J Neurosurg. 2009;111(2):258-64.

  17. Black P, Kathiresan S, Chung W. Meningioma surgery in the elderly: a case-control study assessing morbidity and mortality. Acta Neurochir. 1998;140(10):1013-7.

  18. Bateman BT, Pile-Spellman J, Gutin PH, Berman MF. Meningioma resection in the elderly: nationwide inpatient sample, 1998-2002. Neurosurgery. 2005;57(5):866-72.

  19. Caroli M, Locatelli M, Prada F, Beretta F, Martinelli- Boneschi F, Campanella R, et al. Surgery for intracranial meningiomas in the elderly: a clinical-radiological grading system as a predictor of outcome. J Neurosurg. 2005;102(2):290-4.

  20. Arienta C, Caroli M, Crotti F, Villani R. Treatment of intracranial meningiomas in patients over 70 years old. Acta Neurochir. 1990;107(1):47-55.

  21. Dujovny M, Charbel F, Berman SK, Diaz FG, Malik G, Ausman JI. Geriatric neurosurgery. Surg Neurol. 1987;28(1):10-6.

  22. Kuratsu J, Takeshima H, Ushio Y. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int J Clin Oncol. 2001;6(4):183-91.

  23. Nanda A, Javalkar V, Banerjee AD. Petroclival meningiomas: study on outcomes, complications and recurrence rates. J Neurosurg. 2011;114(5):1268-77.

  24. Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J. Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry. 2000;68(1):25-8.

  25. Oka K, Tsuda H, Kamikaseda K, Nakamura R, Fukui M, Nouzuka Y, et al. Meningiomas and hemorrhagic diathesis. J Neurosurg. 1988;69(3):356-60.

  26. Tomita T, Raimondi AJ. Brain tumors in the elderly. JAMA. 1981;246(1):53-5.

  27. Oka M, Hirazawa K, Yamamoto K, Iizuka N, Hazama S, Suzuki T, et al. Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg. 1996;223(4):434-40.

  28. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery. 1996;119(3):316-25.

  29. Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery. 2005;57(3):538-50.

  30. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol. 1996;29(3):197-205.

  31. Goodwin JW, Crowley J, Eyre HJ, Stafford B, Jaeckle KA, Townsend JJ. A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group Study. J Neurooncol. 1993;15(1):73-7.

  32. Chamberlain MC, Glantz MJ. Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer. 2008;113(8):2146-51.

  33. Newton HB, Scott SR, Volpi C. Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up. Br J Neurosurg. 2004;18(5):495-9.

  34. Chamberlain MC, Tsao-Wei DD, Groshen S. Salvage chemotherapy with CPT-11 for recurrent meningioma. J Neurooncol. 2006;78(3):271-6.

  35. Chamberlain MC. Adjuvant combined modality therapy for malignant meningiomas. J Neurosurg. 1996;84(5):733-6.




2020     |     www.medigraphic.com